FDA Approves First-of-Its-Kind Daily Pill to Drastically Lower Cholesterol

Washington, Thursday, 16 July 2026.
On July 16, 2026, the FDA approved Merck’s Lipfendra, a groundbreaking daily pill that lowers cholesterol far better than traditional statins, offering a cheaper alternative to injections.